Cigna Group Expands Coverage for Home Phototherapy, Benefits Millions with Chronic Skin Conditions

The Cigna Group (NYSE:CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera announced that Cigna has updated its coverage policy for home phototherapy, effective July 15. The change eliminates prior restrictions on the treatment, expanding access for Cigna’s 19.2 million members nationwide who have chronic skin conditions like psoriasis, eczema, and vitiligo. The policy change follows a similar decision by Elevance Health/Anthem, which covers 47.5 million lives. ...